Alset Inc. (NASDAQ:AEI – Get Free Report) saw a significant decrease in short interest in October. As of October 31st, there was short interest totalling 13,000 shares, a decrease of 9.7% from the October 15th total of 14,400 shares. Based on an average trading volume of 42,100 shares, the days-to-cover ratio is presently 0.3 days. Approximately 0.4% of the company’s shares are short sold.
Alset Trading Down 3.7 %
NASDAQ:AEI opened at $1.04 on Monday. The stock has a market capitalization of $9.61 million, a PE ratio of -0.24 and a beta of 1.26. Alset has a 1-year low of $0.46 and a 1-year high of $2.05. The firm has a fifty day simple moving average of $1.39 and a 200 day simple moving average of $1.17.
Insiders Place Their Bets
In other news, CEO Heng Fai Ambrose Chan purchased 6,034,537 shares of the company’s stock in a transaction on Tuesday, September 24th. The shares were purchased at an average price of $0.63 per share, with a total value of $3,801,758.31. Following the purchase, the chief executive officer now directly owns 19,264,692 shares of the company’s stock, valued at $12,136,755.96. This trade represents a 45.61 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 66.70% of the company’s stock.
About Alset
Alset Inc engages in the real estate development, financial services, digital transformation technologies, biohealth activities, and consumer products businesses in the United States, Singapore, Hong Kong, Australia, and South Korea. It operates through four segments: Real Estate, Digital Transformation Technology, Biohealth, and Other Business Activities segments.
Further Reading
- Five stocks we like better than Alset
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- 3 REITs to Buy and Hold for the Long Term
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Alset Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alset and related companies with MarketBeat.com's FREE daily email newsletter.